Loading...
XNAS
DMIIR
Market cap651mUSD
Nov 18, Last price  
0.06USD
1D
18.58%
1Q
-34.07%
Name

Drugs Made In America Acquisition II Corp

Chart & performance

D1W1MN
XNAS:DMIIR chart

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

DMIIU is a Special Purpose Acquisition Company (SPAC), operating as a blank check firm established in the Cayman Islands. Its core objective is to identify and complete a merger or acquisition with an existing business. The company specifically aims to acquire targets within the pharmaceutical and drug industries, driven by the goal of reducing the United States' reliance on international drug manufacturing. Each investment unit comprises one common stock share and an associated right, which entitles the holder to an additional one-tenth of a share once a suitable business combination is successfully finalized.

Key people

Executive Chairman of the Board, Chief Executive Officer · since 2024
Glenn Worman
Chief Financial Officer, Principal Financial and Accounting Officer · since 2025
Chief Financial Officer, Principal Financial and Accounting Officer · since 2025
Catherine Do
Independent Director Nominee
G. Sridhar Prasad
Independent Director Nominee
Myron Shulgan
Independent Director Nominee
URL
IPO date
Sep 25, 2025
Employees
Domiciled in
US
Incorporated in
KY

Valuation

Title
in thousands, except ratios and share amounts
FY
2025‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT